Editor-in-Chief
Hatice Kübra Elçioğlu
Vice Editors
Levent Kabasakal
Esra Tatar
Online ISSN
2630-6344
Publisher
Marmara University
Frequency
Bimonthly (Six issues / year)
Abbreviation
J.Res.Pharm.
Former Name
Marmara Pharmaceutical Journal
Journal of Research in Pharmacy
2024 , Vol 28 , Issue 1
Biophysical and thermodynamical insights into the interaction of mefenamic acid with human serum albumin, based on combined multi-spectroscopic and molecular modeling approaches
1Department of Analytical Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran2Department of Biochemistry, Faculty of Sciences, Payame Noor University, Tehran, Iran
3Nutrition and Food sciences Faculty, Tabriz University of Medical Sciences, Tabriz, Iran
4Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, and Mashhad, Iran DOI : 10.29228/jrp.703 The molecular mechanism of interaction between Mefenamic acid (MA) and human serum albumin (HSA) was investigated. UV-Visible absorption, fluorescence, and FT-IR spectroscopies, with molecular docking, have been used for assay of complex formation, quenching mechanism study, thermodynamic evaluations, and molecular details of the interaction mechanism. The quenching constant (Ksv) of 1.51×105 M-1 was obtained, while the results are indicating the dynamic quenching mechanism. The number of binding sites (n) and apparent binding constants (KA) were 1.51 and 6.55×107 M-1, respectively that resembles positive cooperativity and and strong binding of MA to HSA. The negative sign of standard enthalpy change (ΔH = -88.51 KJ/mol), standard entropy change (ΔS = -146.24 J/mol K), and Gibbs free energy (ΔG = -44.93 KJ/mol) indicated that the van der Waals interactions and hydrogen bonds are facilitating the MA-HSA complex formation. Addition of the metal ions, glucose, urea, and basic pHs decrease the MA-HSA binding constant. Molecular docking simulation showed that mainly positively charged amino acid residues contribute to the MA-HSA interaction. Keywords : Mefenamic acid, NSAID-HSA interaction, Spectroscopy methods, Molecular docking